Compare TRAK & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRAK | STXS |
|---|---|---|
| Founded | 1990 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.2M | 139.3M |
| IPO Year | 1996 | 2004 |
| Metric | TRAK | STXS |
|---|---|---|
| Price | $8.22 | $1.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 73.3K | ★ 472.7K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | ★ 20.69 | 16.67 |
| EPS | ★ 0.28 | N/A |
| Revenue | $21,007,076.00 | ★ $29,346,617.00 |
| Revenue This Year | $6.61 | $28.22 |
| Revenue Next Year | $10.04 | $30.47 |
| P/E Ratio | $29.29 | ★ N/A |
| Revenue Growth | ★ 4.84 | N/A |
| 52 Week Low | $6.94 | $1.24 |
| 52 Week High | $16.11 | $3.59 |
| Indicator | TRAK | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 39.55 |
| Support Level | $8.11 | N/A |
| Resistance Level | $9.06 | $1.96 |
| Average True Range (ATR) | 0.28 | 0.06 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 64.25 | 13.33 |
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.